A bisfluoro analog in the adrafinil/modafinil family marketed for wakefulness; human clinical data are minimal.
Fladrafinil is a chemical relative of the wakefulness drug modafinil (specifically a fluorinated analog), marketed for alertness and focus.
It's believed to share modafinil's basic mechanism — a weak blockade of the dopamine transporter that raises extracellular dopamine and promotes wakefulness — although its specific pharmacology has been poorly characterized.
Human safety and efficacy data are minimal, and it is not an approved medication; it sits in the gray market as a modafinil-like research chemical.
Searching the published record…
Searching the published record…
Searching the published record…
No indexed human data studies found for this term. Try the live PubMed query below.
Search this category on PubMed →No indexed animal studies found for this term. Try the live PubMed query below.
Search this category on PubMed →No indexed in vitro studies found for this term. Try the live PubMed query below.
Search this category on PubMed →Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.